PACS Group, Inc. (NYSE:PACS - Get Free Report) CAO Michelle Lewis sold 3,172 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total transaction of $158,790.32. Following the completion of the sale, the chief accounting officer owned 340,338 shares in the company, valued at approximately $17,037,320.28. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Michelle Renee Lewis also recently made the following trade(s):
- On Thursday, October 29th, Michelle Lewis sold 2,364 shares of PACS Group stock. The shares were sold at an average price of $50.04, for a total transaction of $118,294.56.
- On Wednesday, October 28th, Michelle Lewis sold 9,464 shares of PACS Group stock. The stock was sold at an average price of $50.12, for a total transaction of $474,335.68.
PACS Group Stock Performance
Shares of PACS stock opened at $50.63 on Thursday. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $51.68. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $8.01 billion, a price-to-earnings ratio of 21.32, a price-to-earnings-growth ratio of 1.46 and a beta of -0.14. The business has a 50 day simple moving average of $44.42 and a 200 day simple moving average of $39.91.
PACS Group (NYSE:PACS - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. PACS Group had a net margin of 4.87% and a return on equity of 33.39%. The firm had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.46 billion. On average, equities research analysts anticipate that PACS Group, Inc. will post 2.13 EPS for the current year.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on PACS shares. Truist Financial set a $62.00 target price on PACS Group in a report on Wednesday, September 2nd. UBS Group lifted their price target on PACS Group from $57.00 to $60.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. boosted their price objective on PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a report on Friday, September 4th. Weiss Ratings upgraded PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, October 8th. Finally, Zacks Research lowered shares of PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, PACS Group has a consensus rating of "Moderate Buy" and a consensus target price of $58.80.
Read Our Latest Research Report on PACS
PACS Group News Roundup
Here are the key news stories impacting PACS Group this week:
Institutional Trading of PACS Group
Several hedge funds and other institutional investors have recently modified their holdings of PACS. Dimensional Fund Advisors LP increased its position in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock worth $25,051,000 after purchasing an additional 614,250 shares during the last quarter. Sei Investments Co. raised its stake in shares of PACS Group by 7.4% during the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company's stock worth $11,900,000 after purchasing an additional 25,462 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company's stock worth $9,274,000 after purchasing an additional 89,067 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of PACS Group during the 2nd quarter valued at about $8,196,000. Finally, Corient Private Wealth LP lifted its holdings in shares of PACS Group by 1.8% during the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company's stock valued at $6,517,000 after buying an additional 2,680 shares during the last quarter.
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
